Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium
Maria Carmen Mir(Fundación Instituto Valenciano de Oncología), Peter C. Black(University of British Columbia), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Laura S. Mertens(Oncode Institute), Andrew C. Thorpe(Freeman Hospital), Évanguelos Xylinas(NewYork–Presbyterian Hospital), Wassim Kassouf(McGill University), Petros Grivas(Seattle Cancer Care Alliance), Todd M. Morgan(University of Michigan), Philippe E. Spiess(Moffitt Cancer Center), Niels-Erik Jacobsen(University of Alberta), Yair Lotan(Southwestern Medical Center), Michele Marchioni(University of Chieti-Pescara), Srikala S. Sridhar(Princess Margaret Cancer Centre), Adrian Fairey(University of Alberta), Michael S. Cookson(University of Oklahoma Health Sciences Center), Nikhil Vasdev(University of Hertfordshire), Kamran Zargar‐Shoshtari(University of Auckland), Joshua Griffin(University of Kansas), Scott North, Daniel A. Barocas(Vanderbilt University Medical Center), Jonathan McGrath(Royal Devon & Exeter NHS Foundation Trust), Trinity J. Bivalacqua(University of Pennsylvania), Shahrokh F. Shariat(Universitätszahnklinik Wien), Jonathan L. Wright(Seattle University), Laura‐Maria Krabbe, Marc Dall’Era(University of California, Davis), Evan Y. Yu(University of Washington), J.B. Shah(The University of Texas MD Anderson Cancer Center), Andrew J. Stephenson(Republic of Korea Army), Jeffrey M. Holzbeierlein(University of Kansas Medical Center), Bas W. van Rhijn(University of Regensburg), D. Daneshmand(University of Southern California), Jeffrey S. Montgomery(Ann Arbor Center for Independent Living), Jonathan Aning(Royal Devon and Exeter Hospital)
Cited by 34
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k